【建银国际：上调中国生物制药(01177.HK)目标价至6港元 维持“跑赢大市”评级】智通财经APP获悉，建银国际发布研报称，上调中国生物制药(01177.HK)目标价36.4%，从4.4港元升至6港元，维持“跑赢大市”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.